危重症成人氧中毒:动脉氧合目标的研究进展
本文综述了危重症成人补充氧疗的获益与危害证据。动物实验显示高FiO2导致呼吸衰竭和早期死亡,但人体尸检发现可能混杂呼吸机相关肺损伤。大型随机试验表明保守与宽松氧合目标组临床结局无差异,提示两种策略均合理,特定亚群获益仍需研究。
要点
- 危重症成人保守与宽松氧合目标策略临床结局无差异。
- 心脏骤停人群 targeting 超生理PaO2水平可能有害。
- 补充氧疗普遍,即使小治疗效应也有全球大影响。
核心结论
- 两项最大随机试验显示保守与宽松氧合目标组临床结局无差异,提示两种策略均合理。
- 特定亚群(如心脏骤停) targeting 超生理PaO2水平可能有害。
研究设计与样本
- 综述性文章,汇总动物实验、人体尸检研究、观察性研究及随机临床试验证据。
主要发现
- 动物实验一致显示高FiO2暴露导致呼吸衰竭和早期死亡。
- 1960年代人体尸检研究提示弥漫性肺泡损伤,但可能混杂呼吸机相关肺损伤或其他急性肺损伤原因。
- 一般危重症人群观察性研究显示较高氧暴露与较高死亡率相关,但结果不一致。
- 两项较小随机试验结论相反,两项最大随机试验显示保守与宽松氧合目标组临床结局无差异。
临床怎么用
- 危重症成人可采用保守或宽松氧合目标策略,两者均合理。
- 对心脏骤停患者应避免 targeting 超生理PaO2水平。
局限性
- 人体尸检发现可能混杂呼吸机相关肺损伤或其他急性肺损伤原因。
- 观察性研究结果不一致。
- 特定亚群获益仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oxygen supplementation is one of the most common interventions in critically ill patients. Despite over a century of data suggesting both beneficial and detrimental effects of supplemental oxygen, optimal arterial oxygenation targets in adult patients remain unclear. Laboratory animal studies have consistently showed that exposure to a high FiO2 causes respiratory failure and early death. Human autopsy studies from the 1960s purported to provide histologic evidence of pulmonary oxygen toxicity in the form of diffuse alveolar damage. However, concomitant ventilator-induced lung injury and/or other causes of acute lung injury may explain these findings. Although some observational studies in general populations of critically adults showed higher mortality in association with higher oxygen exposures, this finding has not been consistent. For some specific populations, such as those with cardiac arrest, studies have suggested harm from targeting supraphysiologic PaO2 levels. More recently, randomized clinical trials of arterial oxygenation targets in narrower physiologic ranges were conducted in critically ill adult patients. Although two smaller trials came to opposite conclusions, the two largest of these trials showed no differences in clinical outcomes in study groups that received conservative versus liberal oxygen targets, suggesting that either strategy is reasonable. It is possible that some strategies are of benefit in some subpopulations, and this remains an important ongoing area of research. Because of the ubiquity of oxygen supplementation in critically ill adults, even small treatment effects could have a large impact on a global scale.
引用
- Hochberg CH, Semler MW, Brower RG, et al. Oxygen Toxicity in Critically Ill Adults. Am J Respir Crit Care Med. 2021. PMID: 34086536. doi:10.1164/rccm.202102-0417CI
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。